Paper3762017
[Diagnostic validity of CEA determination in metastasizing breast cancer].
Krieger G and 5 others. Klin Wochenschr, 1986. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. [Diagnostic validity of CEA determination in metastasizing breast cancer]. Papers, record 3762017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3762017
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoembryonic Antigen | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | |
| Combined Modality Therapy | |
| Female | |
| Humans | |
| Neoplasm Metastasis | |
| Prognosis |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 698917 | Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy. | Cancer | 1978 | https://conductscience.org/library/papers/698917 | PubMed |
| 2 | 717986 | Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse. | Ann Intern Med | 1978 | https://conductscience.org/library/papers/717986 | PubMed |
| 3 | 7279699 | Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer. | Oncodev Biol Med | 1980 | https://conductscience.org/library/papers/7279699 | PubMed |
| 4 | 4823478 | Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. | Cancer | 1974 | https://conductscience.org/library/papers/4823478 | PubMed |
| 5 | 6123383 | Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. | Cancer Res | 1982 | https://conductscience.org/library/papers/6123383 | PubMed |
| 6 | 709523 | Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma. | Cancer | 1978 | https://conductscience.org/library/papers/709523 | PubMed |
| 7 | 6174201 | Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen. | Cancer | 1982 | https://conductscience.org/library/papers/6174201 | PubMed |
| 8 | 7126423 | Plasma CEA in the post-surgical monitoring of colorectal carcinoma. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7126423 | PubMed |
| 9 | 6839982 | [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. | Dtsch Med Wochenschr | 1983 | https://conductscience.org/library/papers/6839982 | PubMed |
| 10 | 402435 | [Evaluation of the diagnostic value of clinical chemical tests (author's transl)]. | J Clin Chem Clin Biochem | 1977 | https://conductscience.org/library/papers/402435 | PubMed |
| 11 | 761176 | Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC). | Cancer | 1979 | https://conductscience.org/library/papers/761176 | PubMed |
| 12 | 326384 | The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. | Cancer | 1977 | https://conductscience.org/library/papers/326384 | PubMed |
| 13 | 709522 | Clinical correlation between CEA and breast cancer. | Cancer | 1978 | https://conductscience.org/library/papers/709522 | PubMed |
| 14 | 6218456 | [Mitomycin C and high-dosage medroxyprogesterone acetate in the therapy of metastasizing breast cancer. Results of a phase II study of the Workshop for Internal Oncology of the German Cancer Association]. | Onkologie | 1982 | https://conductscience.org/library/papers/6218456 | PubMed |
| 15 | 912660 | Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. | Cancer | 1977 | https://conductscience.org/library/papers/912660 | PubMed |
| 16 | 392371 | [High-dosage gestagen treatment in the therapy of advanced breast cancer]. | Onkologie | 1979 | https://conductscience.org/library/papers/392371 | PubMed |
| 17 | 639696 | [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)]. | Dtsch Med Wochenschr | 1978 | https://conductscience.org/library/papers/639696 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 1878893 | Prospective assessment of the role of five tumour markers in breast cancer. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1878893 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CEACAM3 | 1084 | PubTator's text mining | https://conductscience.org/library/genes/1084 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3762017
GET https://conductscience.org/api/papers/v1/3762017/authors